CSS
BNTX icon

Cubist Systematic Strategies’s BioNTech BNTX Stock Holding History

Cubist Systematic Strategies’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-25,300
Closed -$2.67M – 3740
2023
Q4 		$2.67M Buy
25,300
+1,500
+6% +$151K 0.02% 1292
2023
Q3 		$2.59M Hold
23,800
– – 0.02% 1189
2023
Q2 		$2.57M Buy
23,800
+3,000
+14% +$337K 0.02% 1294
2023
Q1 		$2.59M Buy
20,800
+10,100
+94% +$1.39M 0.02% 1456
2022
Q4 		$1.61M Sell
10,700
-3,000
-22% -$462K 0.01% 2045
2022
Q3 		$1.85M Buy
13,700
+6,000
+78% +$917K 0.01% 2081
2022
Q2 		$1.15M Buy
+7,700
New +$1.18M 0.01% 2369

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Cubist Systematic Strategies's BNTX Position: Q1 2024 in Review

Cubist Systematic Strategies sold out of BioNTech (BNTX) in Q1 2024, closing a stake of 2,626 shares — an estimated $277K sold.

Cubist Systematic Strategies first reported a position in BNTX in Q4 2020 and held it in 11 quarters. The position peaked at $8.33M in Q1 2023. 287 funds tracked by Wall St. Rank hold BNTX as of Q1 2024.

  • Cubist Systematic Strategies reported no remaining BioNTech position as of Q1 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 2,626 BioNTech shares in Q1 2024, an estimated $277K.
  • Cubist Systematic Strategies first reported a position in BioNTech in Q4 2020 and held it in 11 quarters.
  • Cubist Systematic Strategies's BioNTech position peaked at $8.33M in Q1 2023.
  • 287 funds tracked by Wall St. Rank held BioNTech as of Q1 2024.

Based on Cubist Systematic Strategies's 13F filing for Q1 2024, filed 15 May 2024.